About Reinnervate
Reinnervate is a company based in Sedgefield (United Kingdom) founded in 2002 was acquired by ReproCELL in August 2014. Reinnervate has raised $2 million across 2 funding rounds from investors including ReproCELL, Parkwalk and NorthStar Education Institute. Reinnervate operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Sedgefield, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Reinnervate
Reinnervate has successfully raised a total of $2M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Reinnervate
Reinnervate has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include ReproCELL, Parkwalk and NorthStar Education Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech companies are invested in by Parkwalk venture capital firm.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Leading global supplier of iPS-derived cells, stem cell reagents, human biofluids, and 3D cell culture.
|
Locked | Locked | Locked |
Investor details for Reinnervate
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Reinnervate
Investment portfolio details for Reinnervate
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Reinnervate
Detailed financials for Reinnervate
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reinnervate Comparisons
Peer comparison for Reinnervate
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Reinnervate
Reinnervate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Reinnervate
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reinnervate
Complete news archive for Reinnervate
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reinnervate
Reinnervate was founded in 2002 and raised its 1st funding round 8 years after it was founded.
Reinnervate is headquartered in Sedgefield, United Kingdom. It is registered at Sedgefield, County Durham, United Kingdom.
Reinnervate is a funded company, having raised a total of $2M across 2 funding rounds to date.
Reinnervate (a ReproCELL company), is a spin-out company from Durham University that offers the Alvetex 3D cell culture platform. The technology is based on the research performed by Prof. Stefan Przyborski who also serves as the companys CSO. Alvetex is a highly porous polystyrene scaffold that is engineered into a 200 micron thick membrane. The scaffold is presented in various ways including multi-welled plates and well inserts, for use with conventional culture plasticware and a novel medium perfusion system. Alvetex 3D cell culture enables scientist to grow tissue-like structures that better mimic in vivo biology than current 2D monolayer methods. The potential to improve the predictive nature of cell-based assays by combining 3D culture and iPSC-derived cell products is attracting a lot of interest in the drug development industry. Reinnervates products are currently used by researchers in over 300 universities and companies globally.
Reinnervate's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.